HC Wainwright reaffirmed their buy rating on shares of Dyne Therapeutics (NASDAQ:DYN – Free Report) in a research note released on Wednesday, Benzinga reports. The firm currently has a $36.00 price objective on the stock. HC Wainwright also issued estimates for Dyne Therapeutics’ Q1 2024 earnings at ($0.83) EPS, Q2 2024 earnings at ($0.83) EPS, […]
Dana Investment Advisors Inc. cut its stake in Rocket Pharmaceuticals, Inc. (NASDAQ:RCKT – Free Report) by 7.9% in the third quarter, according to the company in its most recent Form 13F filing with the Securities and Exchange Commission. The fund owned 15,409 shares of the biotechnology company’s stock after selling 1,315 shares during the period. […]
Brokers Issue Forecasts for GlycoMimetics, Inc.'s FY2023 Earnings (NASDAQ:GLYC) themarketsdaily.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from themarketsdaily.com Daily Mail and Mail on Sunday newspapers.
Ocular Therapeutix (OCUL) Announces $325M Private Placement at $7.52/sh streetinsider.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from streetinsider.com Daily Mail and Mail on Sunday newspapers.